PHARMING GROUP NV - ADR (PHAR) Stock Earnings & Estimates
USA - NASDAQ:PHAR - US71716E1055 - ADR
13.79 USD
-1.01 (-6.82%)
14 USD
+0.21 (+1.52%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 205.622M 3.39% | 245.316M 19.30% | 297.2M 21.15% | 349.03M 17.44% | 378.57M 8.46% | 410.02M 8.31% | 441.69M 7.72% | 462.23M 4.65% | 526.01M 13.80% | 485.44M -7.71% | |
| EBITDA YoY % growth | 23.555M -45.99% | -5.825M -124.73% | 12.476M 314.18% | 14.781M 18.48% | 22.351M 51.21% | 31.467M 40.79% | 95.636M 203.92% | 179.33M 87.51% | 235.66M 31.41% | N/A | |
| EBIT YoY % growth | 10.367M -56.80% | -21.75M -309.80% | -3.594M 83.48% | -14.984M -316.92% | 5.562M 137.12% | 43.103M 674.96% | 64.198M 48.94% | 162.51M 153.14% | 218.33M 34.35% | 42.453M -80.56% | |
| Operating Margin | 5.04% | -8.87% | -1.21% | -4.29% | 1.47% | 10.51% | 14.53% | 35.16% | 41.51% | 8.75% | |
| EPS YoY % growth | N/A 101.60% | -0.16 -132.92% | -0.18 -12.50% | 0.38 308.75% | 0.63 67.90% | 0.68 7.76% | 0.79 16.52% | 1.65 107.67% | 2.25 36.51% | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.01 48.50% | -0.06 -223.60% | -0.10 53.18% | 0.10 71.67% | 0.00 100.00% | 0.10 266.67% |
| Revenue Q2Q % growth | 96.233M 28.57% | 97.253M 4.94% | 85.49M 8.09% | 86.52M -7.17% | 88.58M -7.95% | 91.67M -5.74% |
| EBITDA Q2Q % growth | -12.772M -202.35% | -14.317M -162.87% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.107M -273.00% | 4.635M -30.86% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.06 400.00% | -0.26 | 0.32 | 123.30% |
| Q1 2025 Q2Q % growth | -0.22 -15.79% | -0.15 | -0.07 | -42.39% |
| Q4 2024 Q2Q % growth | 0.05 225.00% | 0.07 | -0.02 | -27.22% |
| Q3 2024 Q2Q % growth | -0.02 -140.00% | -0.03 | 0.01 | 22.33% |
| Q2 2024 Q2Q % growth | -0.02 | 0.08 | -0.10 | -124.27% |
| Q1 2024 Q2Q % growth | -0.19 -11.76% | 0.07 | -0.26 | -363.52% |
| Q4 2023 Q2Q % growth | -0.04 80.00% | 0.10 | -0.14 | -138.83% |
| Q3 2023 Q2Q % growth | 0.05 -61.54% | -0.27 | 0.32 | 118.67% |
| Q2 2023 Q2Q % growth | 0.00 -100.00% | -0.12 | 0.12 | 100.00% |
| Q1 2023 Q2Q % growth | -0.17 -423.77% | -0.07 | -0.10 | -153.92% |
| Q4 2022 Q2Q % growth | -0.20 | 0.06 | -0.26 | -430.23% |
| Q3 2022 Q2Q % growth | 0.13 1,201.69% | 0.00 | 0.13 | % |
| Q2 2022 Q2Q % growth | 0.04 -66.78% | 0.10 | -0.06 | -61.66% |
| Q1 2022 Q2Q % growth | 0.05 -60.37% | % | ||
| Q4 2021 Q2Q % growth | 0.00 -100.00% | 0.00 | 0.00 | % |
| Q3 2021 Q2Q % growth | -0.01 -110.09% | 0.00 | -0.01 | % |
| Q2 2021 Q2Q % growth | 0.12 -21.87% | 0.17 | -0.05 | -30.05% |
| Q1 2021 Q2Q % growth | 0.13 9.23% | 0.14 | -0.01 | -7.25% |
| Q4 2020 Q2Q % growth | 0.16 -22.23% | 0.09 | 0.07 | 76.63% |
| Q3 2020 Q2Q % growth | 0.12 -47.41% | 0.20 | -0.08 | -40.11% |
| Q2 2020 Q2Q % growth | 0.15 37.22% | 0.15 | 0.00 | 2.61% |
| Q1 2020 Q2Q % growth | 0.12 6.78% | 0.20 | -0.08 | -38.37% |
| Q4 2019 Q2Q % growth | 0.20 | 0.15 | 0.05 | 29.60% |
| Q3 2019 Q2Q % growth | 0.22 | 0.12 | 0.10 | 80.46% |
| Q2 2019 Q2Q % growth | 0.11 | 0.13 | -0.02 | -15.35% |
| Q1 2019 Q2Q % growth | 0.11 | 0.11 | 0.01 | 8.34% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 93.2M 25.79% | 85.758M | 7.442M | 8.68% |
| Q1 2025 Q2Q % growth | 79.094M 42.29% | 69.767M | 9.327M | 13.37% |
| Q4 2024 Q2Q % growth | 92.672M 14.10% | 83.166M | 9.506M | 11.43% |
| Q3 2024 Q2Q % growth | 74.849M 12.28% | 79.238M | -4.389M | -5.54% |
| Q2 2024 Q2Q % growth | 74.093M 34.97% | 76.668M | -2.575M | -3.36% |
| Q1 2024 Q2Q % growth | 55.586M 30.66% | 70.478M | -14.892M | -21.13% |
| Q4 2023 Q2Q % growth | 81.217M 48.69% | 74.933M | 6.284M | 8.39% |
| Q3 2023 Q2Q % growth | 66.661M 22.90% | 63.18M | 3.481M | 5.51% |
| Q2 2023 Q2Q % growth | 54.897M 9.47% | 54.363M | 534K | 0.98% |
| Q1 2023 Q2Q % growth | 42.541M -8.74% | 49.595M | -7.054M | -14.22% |
| Q4 2022 Q2Q % growth | 54.621M -72.53% | 61.724M | -7.103M | -11.51% |
| Q3 2022 Q2Q % growth | 54.238M 2.60% | 55.62M | -1.382M | -2.48% |
| Q2 2022 Q2Q % growth | 50.146M 0.95% | 53.198M | -3.052M | -5.74% |
| Q1 2022 Q2Q % growth | 46.617M 18.92% | % | ||
| Q4 2021 Q2Q % growth | 198.871M -6.27% | 57.508M | 141.363M | 245.81% |
| Q3 2021 Q2Q % growth | 52.864M 14.62% | 55.686M | -2.822M | -5.07% |
| Q2 2021 Q2Q % growth | 49.673M 26.40% | 69.371M | -19.698M | -28.40% |
| Q1 2021 Q2Q % growth | 39.199M -20.48% | 63.237M | -24.038M | -38.01% |
| Q4 2020 Q2Q % growth | 212.174M 364.64% | 62.49M | 149.684M | 239.53% |
| Q3 2020 Q2Q % growth | 46.121M 1.54% | 56.991M | -10.87M | -19.07% |
| Q2 2020 Q2Q % growth | 39.299M -7.99% | 59.743M | -20.444M | -34.22% |
| Q1 2020 Q2Q % growth | 49.294M 39.94% | 54.624M | -5.33M | -9.76% |
| Q4 2019 Q2Q % growth | 45.664M | 52.989M | -7.325M | -13.82% |
| Q3 2019 Q2Q % growth | 45.423M | 50.724M | -5.301M | -10.45% |
| Q2 2019 Q2Q % growth | 42.711M | 44.837M | -2.126M | -4.74% |
| Q1 2019 Q2Q % growth | 35.224M | 43.01M | -7.786M | -18.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 96.67% | 89.76% | 5880.33% | 92.99% |
| Revenue | 8.79% | 11.23% | 0.7% | 3.64% |